TrialCNS drugs2026

PDE10A Inhibition in Schizophrenia: A Randomised, Placebo-Controlled Phase 2 Study of Alofropodect (CPL'36) in Patients Experiencing Acute Schizophrenia.

Maciej Wieczorek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.